Santhera Pharmaceuticals Holding (SANN) Price & Analysis

Compare

0 Followers

SANN Stock Chart & Stats

Day’s Range― - ―

52-Week RangeCHF7.21 - CHF17.76

Previous CloseN/A

Volume24.19K

Average Volume (3M)22.88K

Market Cap

CHF163.95M

Enterprise ValueCHF162.35M

Total Cash (Recent Filing)CHF40.92M

Total Debt (Recent Filing)CHF40.62M

Price to Earnings (P/E)2.6

Beta0.35

Next Earnings

Sep 10, 2025

EPS Estimate

-0.6

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.74

Shares Outstanding13,577,154

10 Day Avg. Volume15,984

30 Day Avg. Volume22,878

Financial Highlights & Ratios

PEG Ratio0.02

Price to Book (P/B)5.18

Price to Sales (P/S)0.00

P/FCF Ratio-4.56

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF30.00

Price Target Upside136.57% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering1

Santhera Pharmaceuticals Holding News

PremiumThe Fly

Santhera price target raised to CHF 30 from CHF 25 at H.C. Wainwright

2M ago

PremiumRatings

Santhera Pharmaceuticals: Buy Rating Affirmed on Strong Commercial Traction and Promising Financial Outlook

2M ago

PremiumCompany Announcements

Santhera Pharmaceuticals: Transformative Year with AGAMREE Success

2M ago

PremiumRatings

Santhera Pharmaceuticals: Buy Rating Affirmed on Strategic Milestones and Growth Prospects

5M ago

PremiumThe Fly

Santhera price target lowered to CHF 25 from CHF 30 at H.C. Wainwright

10M ago

PremiumThe Fly

Santhera price target raised to CHF 28 from CHF 24 at H.C. Wainwright

2y ago

See All CH:SANN News

See All News >

Bulls Say, Bears Say

Bulls Say

Executive ChangesThe appointment of Catherine Isted as Chief Financial Officer is seen as a positive transition, with the previous CFO remaining available to support the transition.

Funding And AccessibilityFunding from the National Health Service in England is now available for AGAMREE, making it more affordable and accessible for patients with Duchenne muscular dystrophy.

Product RolloutThe European rollout of AGAMREE is accelerating, leading to an increase in the price target for Santhera Pharmaceuticals.

Regulatory ApprovalAGAMREE has received acceptance by Health Canada for the New Drug Submission with Priority Review, paving the way for it to become the first DMD drug approved in Canada.

Bears Say

Pricing ChallengesSanthera continues to engage in pricing negotiations and reimbursement decisions across multiple key European territories, indicating steady progress and market uptake.

Reimbursement ExpectationsThe €52K reimbursement level in Germany exceeds original expectations for European reimbursement, initially projected at only €40K per patient.

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

0.09%

Mutual Funds

― Other Institutional Investors

99.43% Public Companies and

Individual Investors

Detailed Ownership Overview >

SANN FAQ

What was Santhera Pharmaceuticals Holding Ag’s price range in the past 12 months?

Santhera Pharmaceuticals Holding Ag lowest stock price was CHF7.21 and its highest was CHF17.76 in the past 12 months.

What is Santhera Pharmaceuticals Holding Ag’s market cap?

Santhera Pharmaceuticals Holding Ag’s market cap is CHF163.95M.

When is Santhera Pharmaceuticals Holding Ag’s upcoming earnings report date?

Santhera Pharmaceuticals Holding Ag’s upcoming earnings report date is Sep 10, 2025 which is in 53 days.

How were Santhera Pharmaceuticals Holding Ag’s earnings last quarter?

Santhera Pharmaceuticals Holding Ag released its earnings results on Apr 29, 2025. The company reported -CHF0.74 earnings per share for the quarter, the consensus estimate of -CHF0.74 by CHF0.

Is Santhera Pharmaceuticals Holding Ag overvalued?

According to Wall Street analysts Santhera Pharmaceuticals Holding Ag’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Santhera Pharmaceuticals Holding Ag pay dividends?

Santhera Pharmaceuticals Holding Ag does not currently pay dividends.

What is Santhera Pharmaceuticals Holding Ag’s EPS estimate?

Santhera Pharmaceuticals Holding Ag’s EPS estimate is -0.6.

How many shares outstanding does Santhera Pharmaceuticals Holding Ag have?

Santhera Pharmaceuticals Holding Ag has 13,577,154 shares outstanding.

What happened to Santhera Pharmaceuticals Holding Ag’s price movement after its last earnings report?

Santhera Pharmaceuticals Holding Ag reported an EPS of -CHF0.74 in its last earnings report, expectations of -CHF0.74. Following the earnings report the stock price went down -3.141%.

Which hedge fund is a major shareholder of Santhera Pharmaceuticals Holding Ag?

Currently, no hedge funds are holding shares in CH:SANN

Company Description

Santhera Pharmaceuticals Holding Ag

Santhera Pharmaceuticals Holding (SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases. The company is committed to addressing unmet medical needs and improving the quality of life for patients with severe, debilitating conditions. Santhera's core product portfolio includes therapies for Duchenne muscular dystrophy (DMD) and other rare diseases that have limited or no existing treatment options.

SANN Company Deck

SANN Earnings Call

Q4 2025

0:00 / 0:00

SANN Stock 12 Month Forecast

Average Price Target

CHF30.00

▲(136.57%Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"CHF6","12":"CHF12","18":"CHF18","24":"CHF24","30":"CHF30"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":29.9970780023,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.9970780023,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":29.9970780023,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF30.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,12,18,24,30],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2023","6":"Mar<br/>2024","9":"Jan<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.16,14.45515984633077,15.750319692661538,17.045479538992307,18.340639385323076,19.635799231653845,20.930959077984618,22.226118924315386,23.521278770646155,24.816438616976924,26.111598463307693,27.406758309638462,28.70191815596923,{"y":29.9970780023,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.16,14.45515984633077,15.750319692661538,17.045479538992307,18.340639385323076,19.635799231653845,20.930959077984618,22.226118924315386,23.521278770646155,24.816438616976924,26.111598463307693,27.406758309638462,28.70191815596923,{"y":29.9970780023,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,13.16,14.45515984633077,15.750319692661538,17.045479538992307,18.340639385323076,19.635799231653845,20.930959077984618,22.226118924315386,23.521278770646155,24.816438616976924,26.111598463307693,27.406758309638462,28.70191815596923,{"y":29.9970780023,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":14.2,"date":1648771200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.42,"date":1656633600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.25,"date":1688169600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.94,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.59,"date":1701388800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.81,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.5,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.35,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.19,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.82,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.12,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.5,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.16,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >